Shilpa Medicare Limited (SHILPAMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shilpa Medicare Limited net asset quality index to measure how much of total assets are equity-financed.
Shilpa Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Shilpa Medicare Limited to evaluate the quality of earnings relative to operating cash generation.
Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ecovyst Inc
NYSE:ECVT
|
0.029x |
|
Jiangsu Shagang Co Ltd
SHE:002075
|
0.072x |
|
Wacker Neuson SE
F:WAC
|
0.041x |
|
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
|
0.031x |
|
Perpetual Limited
F:PVQ
|
0.041x |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MC:LDA
|
0.278x |
|
GigaCloud Technology Inc Class A Ordinary Shares
NASDAQ:GCT
|
0.132x |
|
Top Glove Corporation Bhd
KLSE:7113
|
0.012x |
Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SHILPAMED market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs23.64 Billion ≈ $255.63 Million |
Rs1.32 Billion ≈ $14.29 Million |
0.056x | -26.35% |
| 2024-03-31 | Rs18.00 Billion ≈ $194.66 Million |
Rs1.37 Billion ≈ $14.78 Million |
0.076x | -40.43% |
| 2023-03-31 | Rs17.74 Billion ≈ $191.89 Million |
Rs2.26 Billion ≈ $24.46 Million |
0.127x | +119.59% |
| 2022-03-31 | Rs18.11 Billion ≈ $195.87 Million |
Rs1.05 Billion ≈ $11.37 Million |
0.058x | +81.52% |
| 2021-03-31 | Rs14.67 Billion ≈ $158.70 Million |
Rs469.28 Million ≈ $5.08 Million |
0.032x | -65.85% |
| 2020-03-31 | Rs13.21 Billion ≈ $142.91 Million |
Rs1.24 Billion ≈ $13.38 Million |
0.094x | -24.09% |
| 2019-03-31 | Rs11.90 Billion ≈ $128.69 Million |
Rs1.47 Billion ≈ $15.87 Million |
0.123x | +196.51% |
| 2018-03-31 | Rs10.80 Billion ≈ $116.78 Million |
Rs449.20 Million ≈ $4.86 Million |
0.042x | +1.43% |
| 2017-03-31 | Rs9.14 Billion ≈ $98.83 Million |
Rs374.77 Million ≈ $4.05 Million |
0.041x | -77.31% |
| 2016-03-31 | Rs7.12 Billion ≈ $77.01 Million |
Rs1.29 Billion ≈ $13.92 Million |
0.181x | +47.44% |
| 2015-03-31 | Rs5.61 Billion ≈ $60.71 Million |
Rs688.06 Million ≈ $7.44 Million |
0.123x | -28.87% |
| 2014-03-31 | Rs4.06 Billion ≈ $43.96 Million |
Rs700.41 Million ≈ $7.57 Million |
0.172x | +29.97% |
| 2013-03-31 | Rs3.29 Billion ≈ $35.60 Million |
Rs436.38 Million ≈ $4.72 Million |
0.133x | -30.71% |
| 2012-03-31 | Rs2.81 Billion ≈ $30.37 Million |
Rs537.36 Million ≈ $5.81 Million |
0.191x | +5.31% |
| 2011-03-31 | Rs2.35 Billion ≈ $25.36 Million |
Rs426.13 Million ≈ $4.61 Million |
0.182x | -65.62% |
| 2010-03-31 | Rs1.01 Billion ≈ $10.95 Million |
Rs535.22 Million ≈ $5.79 Million |
0.528x | +4.69% |
| 2009-03-31 | Rs589.21 Million ≈ $6.37 Million |
Rs297.43 Million ≈ $3.22 Million |
0.505x | +307.88% |
| 2008-03-31 | Rs560.02 Million ≈ $6.06 Million |
Rs69.31 Million ≈ $749.54K |
0.124x | -39.79% |
| 2007-03-31 | Rs418.09 Million ≈ $4.52 Million |
Rs85.93 Million ≈ $929.33K |
0.206x | +203.23% |
| 2006-03-31 | Rs350.17 Million ≈ $3.79 Million |
Rs-69.72 Million ≈ $-753.98K |
-0.199x | -- |
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more